BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

  August 14, 2024

   · 

  12 min read
• Press Releases

  ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results

  August 14, 2024

   · 

  10 min read
• Press Releases

  Avidity Biosciences Announces Proposed Public Offering of Common Stock

  August 14, 2024

   · 

  4 min read
• Press Releases

  $18M ARPA-H award supports Rice-led research on tumor analysis system for breast, head and neck cancer

  August 14, 2024

   · 

  5 min read
• Press Releases

  Clinical Trials to get Underway with Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada

  August 14, 2024

   · 

  6 min read
• Press Releases

  FDA Roundup: August 13, 2024

  August 14, 2024

   · 

  3 min read
• Press Releases

  Invitation to the presentation of ALK’s results for the first six months (Q2) 2024 on Friday 23 August 2024

  August 14, 2024

   · 

  1 min read
• Press Releases

  Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering

  August 14, 2024

   · 

  5 min read
• Press Releases

  Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine

  August 14, 2024

   · 

  4 min read
• Press Releases

  Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update

  August 14, 2024

   · 

  11 min read